Evidence map›Paper›PMID 36555498›Full record

ArticleInternational journal of molecular sciences2022

Vulgarin, a Sesquiterpene Lactone from

Hassan N Althurwi, Gamal A Soliman, Rehab F Abdel-Rahman, Reham M Abd-Elsalam, Hanan A Ogaly, Mohammed H Alqarni, Faisal F Albaqami, Maged S Abdel-Kader

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Foods (Basel, Switzerland) · 2025
    Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Hassan N AlthurwiDepartment of Pharmacology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.ORCID 0000-0003-3548-0852
Gamal A SolimanDepartment of Pharmacology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.ORCID 0000-0003-4622-3501
Rehab F Abdel-RahmanDepartment of Pharmacology, National Research Centre, Giza 12622, Egypt.ORCID 0000-0002-4341-4954
Reham M Abd-ElsalamDepartment of Pathology, College of Veterinary Medicine, Cairo University, Giza 12613, Egypt.
Hanan A OgalyDepartment of Chemistry, College of Science, King Khalid University, Abha 61421, Saudi Arabia.ORCID 0000-0002-0480-5127
Mohammed H AlqarniDepartment of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.ORCID 0000-0002-7061-9111
Faisal F AlbaqamiDepartment of Pharmacology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.ORCID 0000-0001-9343-5713
Maged S Abdel-KaderDepartment of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.
Prince Sattam Bin Abdulaziz University · SACairo University · EGNational Research Centre · EG

Funding

Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia IF-PSAU-2021/03/18755
6 · The paper itself

Abstract

The current investigation assessed the effect of the eudesmanolid, Vulgarin (VGN), obtained from

Indexed as

ArtemisiaDiabetes Mellitus, ExperimentalSesquiterpenesAnimalsAntioxidantsBlood GlucoseGlyburideHypoglycemic AgentsInsulinLactonesPhosphoenolpyruvate CarboxylasePlant ExtractsRatsStreptozocinAntioxidantsBlood GlucoseGlyburideHypoglycemic AgentsInsulinLactonesPhosphoenolpyruvate CarboxylasePlant ExtractsSesquiterpenesStreptozocinG6PasglibenclamidePEPCKratstreptozotocinvulgarin

Identifiers

PMID36555498
PMCPMC9781739
OpenAlexW4311358201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.